The FDA has granted Abbott expanded premarket approval for use of its Absolute Pro stent in treating patients with narrowed iliac arteries. The catheter-delivered device, which has been on the U.S. market since 2008 as a biliary stent, is also being marketed in more than 80 other countries.
FDA OKs expanded use of Abbott's Absolute Pro stent
SmartBrief Job Listings for Health Care
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||
|Compliance and Ethics Director||
Sysmex America, Inc.